TERC and Immunodeficiency: When immortalized G5 mouse Terc−/−Wrn−/−  clones are injected subcutaneously into severe combined immunodeficiency mice, aberrant telomere recombination coupled with the strong selective pressure to maintain telomere length in the absence of telomerase results in the activation of ALT tumors [12].